Product Details
Place of Origin: China
Brand Name: Quickoolchem
Payment & Shipping Terms
Minimum Order Quantity: 50 Grams
Price: Negotiable
Packaging Details: 1~10 KG Aluminum Foil Bag, 25KG/drum
Delivery Time: 1-3 working day
Payment Terms: L/C, L/C, D/A, D/P, T/T, Western Union, MoneyGram
Supply Ability: 10 MT/Month
Molecular Formula: |
C13H19N3O7 |
Appearance: |
White To Off-white Powder |
Purity: |
≥99% |
Solubility: |
Insoluble In Water, Soluble In Organic Solvents |
Cas No.: |
2349386-89-4 |
Odor: |
Odorless |
Sample: |
Available |
Test Method: |
HPLC UV |
Shelf Life: |
24 Months |
Molecular Formula: |
C13H19N3O7 |
Appearance: |
White To Off-white Powder |
Purity: |
≥99% |
Solubility: |
Insoluble In Water, Soluble In Organic Solvents |
Cas No.: |
2349386-89-4 |
Odor: |
Odorless |
Sample: |
Available |
Test Method: |
HPLC UV |
Shelf Life: |
24 Months |
Molnupiravir, also known as EIDD-2801, is an antiviral drug that gained attention for its potential in treating COVID-19. It was originally developed as a treatment for influenza by researchers at Emory University and Ridgeback Biotherapeutics. Molnupiravir works by interfering with the replication process of RNA viruses, including coronaviruses like SARS-CoV-2, the virus responsible for COVID-19.
The drug is a prodrug, which means it gets converted into its active form inside the body. Once metabolized, it introduces errors into the viral genetic material during replication, leading to the accumulation of mutations that can ultimately hinder the virus's ability to spread and cause infection.
Clinical trials have shown promising results in reducing viral load and symptoms in patients with mild to moderate COVID-19. However, as with any medication, further research is needed to fully understand its efficacy, safety profile, and potential side effects. As of my last update, Molnupiravir was undergoing further investigation and evaluation for its role in COVID-19 treatment.
| Item | Value |
|---|---|
| Product Name | Molnupiravir Powder |
| Packaging | 25kg/drum, 1kg/bag, Or According To Customer's Requirements |
| Solubility | Insoluble In Water, Soluble In Organic Solvents |
| Storage | Store In A Cool, Dry Place |
| Appearance | White To Off-white Powder |
| Purity | >=98% |
| Odor | Odorless |
| Cas No. | 2349386-89-4 |
Molnupiravir has been investigated primarily for its potential application in the treatment of viral infections, particularly in the context of COVID-19. Here are some key aspects of its application:
1. COVID-19 Treatment: Molnupiravir gained attention during the COVID-19 pandemic as a potential oral treatment for mild to moderate cases of the disease. Clinical trials have been conducted to assess its efficacy in reducing viral load, alleviating symptoms, and preventing disease progression in COVID-19 patients.
2. Antiviral Mechanism: Molnupiravir works by inhibiting viral replication. It is a prodrug, meaning it is metabolized into its active form in the body. Once activated, it introduces errors into the viral genetic material, leading to the production of defective viruses that are unable to effectively replicate and infect new cells.
3. Potential for Other Viral Infections: While initially developed for influenza, Molnupiravir's broad-spectrum antiviral activity makes it a candidate for treating other RNA viruses. Research is ongoing to explore its efficacy against various viral infections beyond COVID-19, including other coronaviruses, influenza, and potentially even emerging viruses.
4. Oral Administration: One of the advantages of Molnupiravir is its oral administration, which makes it more convenient and accessible compared to some other antiviral drugs that require intravenous administration.
5. Early Treatment: Molnupiravir has shown promise as an early treatment option for COVID-19, with the potential to reduce the severity of the disease and decrease the risk of complications when administered early in the course of infection.
As with any medication, the application of Molnupiravir is subject to ongoing research, regulatory approval processes, and clinical guidelines. Its efficacy, safety profile, and optimal use in various clinical settings continue to be investigated and refined.
